- 1. (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-Octadecahydro-3',6',10,11b-tetramethylspiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b
- (UMLS (NCI) C0056789) =Organic Chemical ;
| - 4. 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-3H-1,2,4-Triazol-3-one
- [A small molecule, high-affinity substance P antagonist (SPA) with antiemetic activity. Crossing the blood brain barrier, aprepitant binds selectively to the human substance P/neurokinin receptor in the central nervous system (CNS), thereby inhibiting receptor binding of endogenous substance P and substance P-induced emesis. This agent has little or no affinity for serotonin (5-HT3), dopamine, and corticosteroid receptors. ( NCI )] (UMLS (NCI) C1176306) APREPITANT;
APREPITANT UNIDENTIFIED; APREPITANT PREPARATION; APREPITANT UNIDENTIFIED =Organic Chemical; Pharmacologic Substance =[GA700] ANTIEMETICS; Unclassified Ingredients =APREPITANT 125 MG; APREPITANT 80 MG; APREPITANT 125MG X1/80MG X2 CAP,PKT,3 |
- 2. (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[(3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentad
- [semi-synthetic macrolide antibiotic; related to erythromycin. ( CSP )] (UMLS (NCI) C0052796) =Organic Chemical; Antibiotic =macrolide antibiotic;
ERYTHROMYCIN; [AM200] ERYTHROMYCINS/MACROLIDES; =AZITHROMYCIN DIHYDRATE; AZITHROMYCIN 100 MG/5ML; AZITHROMYCIN 250 MG; AZITHROMYCIN 200 MG/5ML; AZITHROMYCIN 600 MG; AZITHROMYCIN 500 MG; | - 5. RSR 13
- [A drug that may increase the effectiveness of radiation therapy. ( NCI )] (UMLS (NCI) C0165792) =Organic Chemical; Pharmacologic Substance
|